Combivent UDV 10’s
KSh 1,999.00
Combivent UDV is a nebulizer solution combining two active ingredients used to manage breathing difficulties associated with chronic obstructive pulmonary diseases (COPD), including chronic bronchitis and emphysema. Each unit dose vial delivers a precise combination of active substances, which work together to open up the airways and make breathing easier. Active Substances: Ipratropium Bromide (0.5mg) and Salbutamol (2.5mg) per UDV.
Anti-Asthmatics
Suggested Use
Combivent UDV is indicated for:
- Symptomatic relief of bronchospasms in patients with COPD.
- Enhancing airflow in cases of chronic bronchitis and emphysema.
- Providing combined bronchodilator therapy for patients unresponsive to single-agent treatments.
Dosage and Administration:
- Recommended Dose for Adults:
1 unit dose vial (UDV) inhaled via nebulization 3-4 times daily. - Administration:
- Use a nebulizer for administration.
- Ensure the solution is used immediately after opening the vial.
- Do not mix with other nebulizer medications unless recommended by a physician.
Note: Dosage should be adjusted by a healthcare provider based on the severity of the condition.
Warning
- Contraindications: Do not use if allergic to ipratropium, salbutamol, or any other components. Avoid in patients with hypertrophic obstructive cardiomyopathy or tachyarrhythmia.
- Special Precautions:
- Use cautiously in patients with glaucoma, prostatic hypertrophy, or bladder-neck obstruction.
- Monitor for potential hypokalemia, especially in patients with cardiovascular issues.
- In cases of acute dyspnea that does not improve, seek immediate medical attention
- Combivent UDV must only be used with a nebulizer and should not be taken orally or injected.
The solution contains no preservatives; therefore, it should be used immediately after opening to prevent contamination